|Bid||256.10 x 800|
|Ask||279.75 x 900|
|Day's range||267.06 - 271.24|
|52-week range||206.19 - 424.00|
|Beta (5Y monthly)||1.15|
|PE ratio (TTM)||32.51|
|Earnings date||16 Feb 2023|
|Forward dividend & yield||0.76 (0.28%)|
|Ex-dividend date||24 Jan 2023|
|1y target est||284.88|
McKesson (MCK) delivered earnings and revenue surprises of 8.83% and 0.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex woes persist.
Shares of West Pharmaceutical Services (NYSE: WST) were down 11.7% as of 11:14 a.m. ET on Thursday. West reported Q3 net sales of $686.9 million, down 2.8% year over year. It now expects net sales will be between $2.83 billion and $2.84 billion compared to the previous forecast of $2.95 billion to $2.975 billion.